Clinical Trials
41 trialsFRAmework-01
Eli Lilly and Company
PIPACOVA
Hospices Civils de Lyon
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
Oncoinvent Solutions AS
STOPGAP II
Eastern Cooperative Oncology Group
Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)
Ciusss de L'Est de l'Île de Montréal
iCaRe2
University of Nebraska
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
GE Healthcare
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
National Institutes of Health Clinical Center (CC)
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
PrimPIPAC
Moscow Regional Oncological Dispensary
EPICH
Fondazione del Piemonte per l'Oncologia
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.
Unidade Local de Saúde São João
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Jules Bordet Institute
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
University of California, Irvine
Charlie-2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
NUCLEAR
Hospices Civils de Lyon
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
Memorial Sloan Kettering Cancer Center
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
University of Colorado, Denver
COCOON
Institut du Cancer de Montpellier - Val d'Aurelle
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
City of Hope Medical Center
ALBUCHIP
Assistance Publique - Hôpitaux de Paris
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
University of Chicago
MATAO
Swiss GO Trial Group
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
University of California, Irvine
PIPAC-NAL-IRI
University Hospital, Ghent
Hi-STEP1
Technische Universität Dresden
Preventive Use of PIPAC in Locally Advanced Gastric Cancer.
National Research Oncology and Transplantology Center, Kazakhstan
FAPeCa
Jules Bordet Institute
BCBOvaire
Institut du Cancer de Montpellier - Val d'Aurelle
GECOP-MMC
Hospital Universitario de Fuenlabrada
Galunisertib Combined With Capecitabine in Advanced CRC With PM
The Netherlands Cancer Institute
HIPEC
Universitaire Ziekenhuizen KU Leuven
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis
National University Hospital, Singapore
CRS-IP
National Taiwan University Hospital
Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction
Sixth Affiliated Hospital, Sun Yat-sen University
Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients
Odense University Hospital
CRS/HIPEC
University of Regensburg
PSM
Oslo University Hospital
PITCHER (Peritoneal Carcinomatosis Heterogeneity)
Hospices Civils de Lyon
GASPACCO
St. Petersburg State Pavlov Medical University